APLS.NASDAQApellis Pharmaceuticals, INC
Form 4: Apellis Pharmaceuticals CFO Transfers Shares to Irrevocable Trust
Sentiment:
SEC Form 4 Filing
Timothy Eugene Sullivan, CFO of Apellis Pharmaceuticals, transferred 14,164 shares of common stock to The Timothy E Sullivan Irrevocable Trust of 2023 on April 18, 2024.
Summary
- On April 18, 2024, Timothy Eugene Sullivan, the Chief Financial Officer of Apellis Pharmaceuticals, transferred 14,164 shares of Apellis Pharmaceuticals common stock to The Timothy E Sullivan Irrevocable Trust of 2023.
- Following the transaction, Sullivan directly owns 79,174 shares and indirectly owns 70,396 shares through the trust.
- Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023.
- Sullivan disclaims beneficial ownership over the shares held by the trust except to the extent of his pecuniary interest therein.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to a share transfer, indicating a neutral sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of the share transfer to The Timothy E Sullivan Irrevocable Trust of 2023 |
| 04/19/2024 | Date of signature of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.